Beryl Drugs Ltd.
Snapshot View

12.65 -0.85 ▼-6.3%

07 December 2022, 03:31:00 PM
Volume: 1,455

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.beryldrugs.com
Market Cap 6.42 Cr.
Enterprise Value(EV) 10.85 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -0.03 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 34.96 Trailing Twelve Months Ending 2022-09
Book Value / Share 15.41 Trailing Twelve Months Ending 2022-09
Price to Book Value 0.82 Calculated using Price: 12.65
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.51 Cr. 5,071,700 Shares
FaceValue 10
Company Profile
Beryl Drugs incorporated in 1993 is into manufacturing and marketing of branded, generic pharmaceutical formulations. The company is one of leading manufacturer of I.V.fluids and small volume injectables.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-6.30%
1 Week
+15.00%
1 Month
+27.91%
3 Month
+40.56%
6 Month
+48.65%
1 Year
+25.25%
2 Year
+80.71%
5 Year
+23.29%
10 Year
-52.89%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 4.26 1.31 2.54 1.74 14.80 8.35 0.63 3.09 -8.68
Return on Capital Employed (%) 8.35 4.92 5.55 4.48 16.88 9.96 4.05 6.28 -3.82
Return on Assets (%) 2.90 0.83 1.62 1.11 9.08 4.67 0.31 1.35 -3.62

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 6 7 7 7 7 8 8 8 7 8
Non Curr. Liab. 0 0 0 0 0 1 3 3 2 2
Curr. Liab. 3 4 3 4 4 6 7 8 8 8
Minority Int.
Equity & Liab. 10 11 10 11 11 14 17 19 18 18
Non Curr. Assets 5 4 4 4 4 9 9 9 7 7
Curr. Assets 5 6 6 7 7 5 8 10 11 11
Misc. Exp. not W/O
Total Assets 10 11 10 11 11 14 17 19 18 18

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 15 13 13 11 15 13 13 14 15 20
Other Income 0 0 0 0 1 0 0 0 0
Total Income 15 14 13 11 16 13 13 14 15 20
Total Expenditure -14 -13 -13 -11 -14 -12 -12 -13 -14 -18
PBIDT 1 1 1 1 2 1 1 2 1 1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 -1 0 0 0 0 -1 -1 -1 -1
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items 0
PAT 0 0 0 0 1 1 0 0 -1 0
Adjusted EPS 1 0 0 0 2 1 0 0 -1 0

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1 0 1 0 0 0 3 0 0 0
Cash Fr. Inv. -1 0 0 0 0 0 -5 -2 0 1
Cash Fr. Finan. 0 0 0 0 0 0 2 2 -1 0
Net Change 0 0 1 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 1 1 1 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 24.92 24.92 24.92 24.92 24.92 24.92 24.92 24.92 24.92
Public 75.08 75.08 75.08 75.08 75.08 75.08 75.08 75.08 75.08
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 16 Nov 2022
RELATED PARTY DISCLOSURE
RELATED PARTY DISCLOSURE
Tue, 15 Nov 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
NEWSPAPER PUBLICATION 30.09.2022
Mon, 14 Nov 2022
Board Meeting Outcome for OUTCOME OF BOARD MEETING
OUTCOME OF BOARD MEETING

Technical Scans View Details >>

Wed, 07 Dec 2022
High Delivery Percentage High Delivery Percentage
Opening at Low Opening at Low
High Increase 1 Month High Increase 1 Month
High Increase 3 Months High Increase 3 Months
High Increase 6 Months High Increase 6 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 244,600.20 1,017.75 -1.5%
Cipla Ltd. 89,185.65 1,105.30 -0.4%
Divi's Laboratories Ltd. 88,620.05 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. 72,619.02 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. 67,995.76 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. 55,031.23 1,629.00 +0.9%
Abbott India Ltd. 42,993.71 20,208.95 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 59.59 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-09 34.76 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-09 29.63 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.32 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 80.98 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 69.05 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-09 48.76 20,208.95 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.60 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-09 4.08 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-09 7.31 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.49 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.36 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.03 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-09 15.84 20,208.95 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-03 0.00 20,208.95 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-03 29.95 20,208.95 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-03 29.95 20,208.95 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,208.95 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-03 798.70 20,208.95 +0.1%

FAQ's On Beryl Drugs Ltd.

What is Beryl Drugs share price?

Can I buy Beryl Drugs shares now?

What is the Market Cap of Beryl Drugs?

What are the key metrics to analyse Beryl Drugs?

What is the 52 Week High and Low of Beryl Drugs?

What is the trend of Beryl Drugs share price?